# A Trial of 18F-AV-133 Positron Emission Tomography (PET)

> **NCT01515384** · PHASE1 · TERMINATED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 19 (actual)

## Conditions studied

- Type 1 Diabetes
- Type 2 Diabetes

## Interventions

- **DRUG:** 18F-AV-133

## Key facts

- **NCT ID:** NCT01515384
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515384, "A Trial of 18F-AV-133 Positron Emission Tomography (PET)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01515384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*